Managing Acute Vaso-Occlusive Crises in Sickle Cell Disease
Researchers have sought to determine better ways to manage patients with SCD experiencing pain or a vaso-occlusive sickle cell crisis.
Home
Germline Predisposition to Myeloid Neoplasms Seen in Adults With Bone Marrow Hypocellularity
Researchers sought to determine whether there were predispositions to myeloid neoplasms contributed to cytopenias and hypoplastic bone marrow in adult patients.
Final Results of DREAMM-2 Show Durable Responses With Belantamab Mafodotin
Final results from the DREAMM-2 trial suggest that belantamab mafodotin produces durable responses in patients with relapsed/refractory multiple myeloma.
Vigilance, Rapid Interventions Key to Chemotherapy Reaction Management
Quickly recognizing and intervening to manage chemotherapy reactions can be a matter of life or death; this review of the signs can help oncology nurses know how to respond.
Pulmonary Embolism-Related Mortality Remained Unchanged From 2006 to 2019
Age-adjusted mortality rate increased for men versus women and Black versus White patients.
Survey Reveals Disparities in Management of CALR-Mutated Essential Thrombocythemia
Researchers sought to determine the management of CALR-mutated essential thrombocythemia that has progressed for patients in Australia.
Higher Rate of Infections After AHCT for Multiple Myeloma Seen in India
Researchers sought to determine rates of infections for patients with multiple myeloma receiving autologous transplantation in India compared to other countries.
Pain Management Barriers Nurses Can Help Cancer Survivors Navigate
Cancer survivors face bias, confusion, and other barriers to pain medication access; oncology nurses can help them overcome these barriers.
Oncologists Receive More EHR Messages Than Other HCPs but Spend Less Time in EHRs
A new study suggests that electronic health records could be better tailored to meet the specific needs of oncologists.
Acalabrutinib Has Superior Safety Profile to Ibrutinib in Previously Treated CLL
Researchers sought to determine whether acalabrutinib would be superior to ibrutinib in patients with previously treated CLL.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Leukemia
Loading... 
Loading...